|Day Low/High||0.05 / 0.05|
|52 Wk Low/High||0.02 / 0.75|
Broader European Launch Planned for New Altura Endovascular Stent Graft
Company exhibit to include a 'hands-on' learning center for new Altura Endovascular Stent Graft and Aorfix with the IntelliFlex LP Delivery System
Launch Reference Centers Continue to be Established in the UK and Germany
Event Featured Technical Review and Live Case Presentations
Dainis Krievins, MD Will Present at Late Breaking AAA Presentation
No Immediate Effect on Listing - EVAR Has 180 Days to Regain Compliance
Patient Successfully Treated Using the Revolutionary Altura Endovascular Stent Graft
Patient Was Successfully Treated Using the Revolutionary Altura Endovascular Stent Graft
First Ever Live Case Presentation Highlighted Revolutionary Product Advantages
Scientific Presentations on Aorfix™ and New Altura Stent Graft Systems Also Scheduled
These stocks trading for less than $10 a share are within range of triggering breakout trades.
Longer-Term Positive Outcomes in Abdominal Aortic Aneurysm Patients With Standard and Challenging Anatomies Reinforce the Broad Clinical Value of Aorfix
Debut of Data on New IntelliFlex(TM) Delivery System and Early Clinical Experience With Altura
Design Enhances Control and Precision During Placement and Reduces Potential for Vessel Trauma
Year-to-Date Aorfix Revenue Up 43 Percent Year-over-Year; Market Share in Japan Exceeds Five Percent in First Year of Sales
Outcomes Similar to EVAR Trials With Less Challenging Anatomy
Lombard Estimates 5% Market Share Achieved
TheStreet highlights 3 stocks that pushed the Health Services industry
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.